ReviewWorld journal of clinical oncology2021

Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors.

Evgeny Imyanitov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.